Latest filing published 08 Apr 2024 for NGM Biopharmaceuticals INC.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Hsiao D. Lieu: trading record in brief
Hsiao D. Lieu discloses dealings in NGM Biopharmaceuticals Inc to SEC (Form 4). In total, 9 filings cover trades dated from 15 May 2020 to 5 April 2024.
Sales make up the whole of the open-market record (4 sales, €274k). Besides market trades, the filings include 2 share grants and 2 option exercises.
Most recently, on 8 April 2024, the filings show a transaction in NGM Biopharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Hsiao D. Lieu
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 19,349 sharesCommon StockSEC:0000950170-24-042583:0
- 5,430 shares@ US$1.344.9% of flowCommon StockSEC:0001415889-24-001544:0
- 53,000 shares0Common StockSEC:0001209191-23-016392:0
- 2,000 shares@ US$12.0629.0% of flowCommon StockSEC:0001209191-21-059996:0
- 2,258 shares@ US$23.0061.7% of flowCommon StockSEC:0001209191-21-051396:0
5 of 5 declarations